Banner - Collaborative Care Symposium
News
All NewsContributorsMoney Matters
Media
All VideosExpert InterviewsMedical World NewsPodcastsCase Based Roundtable SeriesCase of the QuarterEyeViewGrand RoundsInsightsRapid ReadoutViewpointsWhat’s Your WhEYE?
Conferences
Conference CoverageConference Listing
Events
More
Publications
Digital EditionEurope Ophthalmology TimesModern RetinaSupplements and Featured Publications
CME
Partners
Resources
Job BoardSponsored

Subscribe

  • News
  • Media
  • Conferences
  • Events
  • Publications
  • CME
  • Partners
  • Subscribe
  • Resources
  • AMD
  • Biosimilars
  • COVID-19
  • Cataract
    • Cataract Surgery
  • Cataract Therapeutics
  • Clinical Diagnosis
    • The Residency Report
    • iOpeners
    • NeuroOp Guru
  • Cornea
  • DME
  • Dry Eye
    • Dry Eye Awareness
  • Gene Therapy
  • Geographic Atrophy
  • IOL
    • IOL Advances
  • Imaging
  • Interventional Glaucoma
    • Glaucoma Awareness
    • Glaucoma Insights
    • Therapeutic Glaucoma
  • OCT
  • Ocular Allergy
  • Ocular Surface Disease
  • Optic Relief
  • Optometry
  • Pediatrics
  • Pharmacy
  • Practice Management
    • Indispensable
  • Presbyopia
  • Ptosis
  • Refractive
    • Refractive Surgery
  • Retina
  • Surgery
  • Technology
  • Therapeutics
  • Understanding Antibiotic Resistance
  • Workplace
Spotlight -
Retina
Advertisement

Alexis Pascoe

Advertisement

Articles by Alexis Pascoe

Grave’s disease

Considering use of teprotumumab in thyroid eye disease patients

ByAlexis Pascoe,Iyza F. Baig,Andrew G. Lee, MD
October 22nd 2018

There is need for alternative treatment to circumvent current treatment limitations

Exploring tocilizumab for giant cell arteritis cases

ByIyza F. Baig,Alexis Pascoe,Andrew G. Lee, MD
August 27th 2018
Advertisement

Latest Updated Articles

  • Exploring tocilizumab for giant cell arteritis cases
    Exploring tocilizumab for giant cell arteritis cases

    Published: August 27th 2018 | Updated:

  • Grave’s disease
    Considering use of teprotumumab in thyroid eye disease patients

    Published: October 22nd 2018 | Updated:



Advertisement
Advertisement

Trending on Ophthalmology Times - Clinical Insights for Eye Specialists

1

FDA clears IND for Complement Therapeutics’ CTx001 gene therapy in geographic atrophy

2

STAAR and Broadwood conflict over proposed Alcon merger continues

3

Ocular surface: Targeted therapies for a multifactorial problem

4

Finding your fit: Excimer lasers and early surgical practice

5

Study finds retinal progenitor cell injections improve outcomes in rat model of diabetic retinopathy

  • About
  • Advertise
  • Privacy
  • Editorial Info
  • Editorial Board
  • Terms and Conditions
  • Contact Us
  • Do Not Sell My Personal Information
  • Job Board
Contact Info

259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831

609-716-7777

  • Ophthalmology Times
  • Modern Retina
  • Optometry Times
  • Ophthalmology Times Europe
EyeCare Network
Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us